About Coultreon
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
coultreon.com
Domain Registered Date
Mar 16, 2026
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $125,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
coultreon.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Coultreon.
Funding History
Series-A
· Apr 28, 2026
$125,000,000 fundraisingfox.com
Founders & Leadership
Fabrice Kolb
Head of Immunology Co-founder
Work email & phone locked
Unlock →
Guy Peeters
Chief Financial Officer Co-founder
Work email & phone locked
Unlock →
John-Paul Gallivan
Head of Development Co-founder
Work email & phone locked
Unlock →
Marie De Vulder
Chief Legal Officer Co-founder
Work email & phone locked
Unlock →
Pierre Raboisson
Chief Executive Officer Chief Scientific Officer Co-founder
Work email & phone locked
Unlock →
Pieter Peeters
Operating & Technology Officer Co-founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026